Publications

Since the Trump administration took office in 2025, a marked shift in federal consumer financial protection policy has left many industry stakeholders reassessing the regulatory landscape. With the Consumer Financial Protection Bureau (CFPB) in particular scaling back enforcement activity and narrowing its supervisory focus, industry stakeholders have turned their attention […]

Recently, the Department of Labor (“DOL”) issued four opinion letters interpreting the Fair Labor Standards Act (“FLSA”). As a general rule, the FLSA requires covered employers to pay at least the federal minimum wage for all hours worked and to compensate non-exempt employees at one and one-half times their regular […]

The IRS has announced the 2027 cost-of-living adjustments for health savings accounts (HSAs), high-deductible health plans (HDHPs), and health reimbursement arrangements (HRAs): HSA Contribution Limits – the 2027 annual HSA contribution limit is $4,500 for individuals with self-only HDHP coverage (up from $4,400 in 2026), and $9,000 for individuals with […]

The price of prescription drugs remains a major concern for employers and employees, and the Trump Administration has made reducing costs and increasing transparency related to pharmacy benefits and prescription drugs a priority.  A central focus of that effort has been the regulation of pharmacy benefit managers (PBMs).  PBMs are […]

On March 30, 2026 the Department of Labor (“DOL”) issued a notice of proposed rulemaking (the “Proposed Rules”) entitled: “Fiduciary Duties in Selecting Designated Investment Alternatives.”  Per the DOL, the purpose of the rule is to “alleviate certain regulatory burdens and litigation risk” associated with a plan’s designated investment alternatives—including […]